Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QJL8 | ISIN: US15687V1098 | Ticker-Symbol: 700
Berlin
02.05.24
10:50 Uhr
16,145 Euro
+0,130
+0,81 %
Branche
Software
Aktienmarkt
S&P SmallCap 600
1-Jahres-Chart
CERTARA INC Chart 1 Jahr
5-Tage-Chart
CERTARA INC 5-Tage-Chart
RealtimeGeldBriefZeit
15,83516,48012:07
15,83516,48011:52

Aktuelle News zur CERTARA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.04.Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference2
04.04.Decoding 4 Analyst Evaluations For Certara5
01.03.Earnings call: Certara announces Q4 growth and 2024 revenue outlook8
01.03.Analyst Scoreboard: 4 Ratings For Certara8
01.03.UBS raises Certara shares price target to $20 from $17, expects growth8
01.03.Certara Inc reports results for the quarter ended in December - Earnings Summary4
29.02.Certara Non-GAAP EPS of $0.09 misses by $0.02, revenue of $88M beats by $1.32M5
29.02.Certara, Inc. - 10-K, Annual Report1
29.02.Certara, Inc. - 8-K, Current Report1
29.02.Certara Reports Fourth Quarter 2023 Financial Results189PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023....
► Artikel lesen
01.02.Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference7
13.12.23Certara acquires Applied BioMath6
13.12.23Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies235PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced it has acquired Applied BioMath, an industry-leader in providing model-informed drug discovery and development...
► Artikel lesen
21.11.23Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development985PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp Biopharmaceutics software. It is designed...
► Artikel lesen
10.11.23Certara, Inc. (CERT) Q3 2023 Earnings Call Transcript3
09.11.23Certara Inc reports results for the quarter ended in September - Earnings Summary7
08.11.23Certara Non-GAAP EPS of $0.11, revenue of $85.6M6
08.11.23Certara, Inc. - 10-Q, Quarterly Report2
08.11.23Certara, Inc. - 8-K, Current Report2
08.11.23Recap: Certara Q3 Earnings1
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1